Comparison of Artificial Intelligence and Clinicians With Different Experience Levels in Assessing Gingival Phenotype

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorOndokuz Mayıs University

About this trial

The goal of this observational study is to compare the performance of clinicians with different experience levels and a deep learning-based artificial intelligence (AI) model in assessing gingival phenotype using two diagnostic methods: the periodontal probe transparency method and visual assessment from standardized clinical photographs. The main questions the study aims to answer are:

Can AI achieve comparable accuracy to human examiners in both probe transparency and visual assessment methods?

Does examiner experience level influence diagnostic performance and agreement with the reference standard in these methods?

Researchers will compare AI, dental students, and periodontology research assistants to determine accuracy, sensitivity, specificity, and agreement with the gold standard for each method.

Participants will:

Undergo standardized intraoral photography of maxillary anterior teeth, with and without a periodontal probe in place, following a validated protocol.

Have gingival phenotype determined by a reference periodontologist using the probe transparency method as the gold standard.

Have their photographs evaluated by AI, dental students, and research assistants for phenotype classification using both methods.

Eligibility criteria

Qualifiers

Systemically and periodontally healthy individuals.

Presence of natural maxillary anterior incisors.

Disqualifiers

Presence of fixed crowns or cervical restorations on the evaluated teeth.

Pregnant or breastfeeding women.

Signs of gingival inflammation or periodontal disease with attachment loss.

Presence of buccal gingival recession.

Trial design

Treatments tested in this trial

  • Periodontal Probe Transparency Method
  • Visual Assessment Method
  • Deep Learning-Based Artificial Intelligence Model

Treatment groups

40 Participants
are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators